Related Experiment Videos
Diabetes mellitus in patients with benign prostatic hyperplasia
Insights
Benign prostatic hyperplasia (BPH) is linked to increased risks of diabetes and heart conditions in older men. These findings support the theory that hormonal changes, specifically increased estrogen, contribute to BPH development.
Area of Science:
- Urology
- Endocrinology
- Geriatrics
Background:
- Benign prostatic hyperplasia (BPH) is a common condition in aging men.
- Comorbidities like diabetes and cardiovascular disease are prevalent in this demographic.
Purpose of the Study:
- To investigate the prevalence of diabetes and cardiac issues in patients undergoing surgery for BPH.
- To explore potential links between BPH and hormonal changes associated with aging.
Main Methods:
- Retrospective analysis of 51 patients undergoing surgery for BPH.
- Assessment of patient history for diabetes, peptic ulcer surgery, and cardiac events (myocardial infarction, ischemia).
Main Results:
- 5.9% of patients had pre-existing diabetes; an additional 47.9% of the remaining cohort were found to be diabetic.
- 40% of patients had a history of or evidence of cardiac infarction or myocardial ischemia.
- Two patients had prior surgery for peptic ulcer disease.
Conclusions:
- The high prevalence of diabetes and cardiac comorbidities suggests a potential link between BPH and systemic metabolic or hormonal factors.
- Findings support the hypothesis that BPH may be a manifestation of relative increases in estrogen secretion with aging.
Abstract:
Of 51 patients submitted to operation for benign prostatic hyperplasia three (5.9%) were knwon, diabetics and two others had undergone surgery for peptic ulcer. Of the remaining patients half (23 out of 46) were found to be diabetic; 40% (20 patients) had a history of previous cardiac infarction or electrocardiograph evidence of myocardial ischaemia.It is suggested that these findings add further support to the hypothesis that benign prostatic hyperplasia is one manifestation of a relative increase of oestrogen secretion with advancing age.